Health Insurance - Required Coverage - Hormone-Related Care
HB 1435 requires Maryland health insurance companies, nonprofit health plans, and health maintenance organizations to cover hormone-related care for perimenopausal and menopausal symptoms. This includes hormone therapy, hormone-modulating medications, related lab testing, and clinical visits, with coverage not denied based on diagnosis (like menopause symptoms), age, or prior treatment history. The bill prohibits extra approval steps, stricter limitations, or higher costs for this care compared to similar treatments. It also mandates that coverage decisions follow evidence-based guidelines and the treating provider’s clinical judgment, ensuring timely access to care.
Bill status
in committee
1 of 4 stages cleared
Introduction
Feb 2026
Committee Review
Floor Vote
Governor
Introduced Feb 13, 2026
Last action Mar 13, 2026
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
5
Key actions
0
Committee
1
Feb 13, 2026
Committee
First Reading Health
lower
11 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Aaron Kaufman
DDemocratic
P
Anne Kaiser
DDemocratic
P
April Miller
RRepublican
P
April Rose
RRepublican
P
Charlotte Crutchfield
DDemocratic
P
Chris Tomlinson
RRepublican
P
Christopher Bouchat
RRepublican
P
Kevin Hornberger
RRepublican
P
Linda Foley
DDemocratic
P
Ryan Spiegel
DDemocratic
P
Teresa Woorman
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about HB 1435
Scope: MD
Hi! I can help you understand HB 1435. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline